218 related articles for article (PubMed ID: 17939545)
1. Argyrophilic nucleolar organizing regions and Ki67 equally reflect proliferation in fine needle aspirates of normal, hyperplastic, inflamed, and neoplastic canine lymph nodes (n = 101).
Bauer NB; Zervos D; Moritz A
J Vet Intern Med; 2007; 21(5):928-35. PubMed ID: 17939545
[TBL] [Abstract][Full Text] [Related]
2. Use of the argyrophilic nucleolar region method for cytologic and histologic examination of the lymph nodes in dogs.
Vajdovich P; Psáder R; Tóth ZA; Perge E
Vet Pathol; 2004 Jul; 41(4):338-45. PubMed ID: 15232133
[TBL] [Abstract][Full Text] [Related]
3. Morphometric analysis of AgNORs in the lymph node lesions.
Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
[TBL] [Abstract][Full Text] [Related]
4. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
Arora B; Kumar S; Jain R
J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
[TBL] [Abstract][Full Text] [Related]
5. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
7. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results of clinicians' assessments, cytologic examination of fine-needle lymph node aspirates, and flow cytometry for determination of remission status of lymphoma in dogs.
Williams LE; Broussard MT; Johnson JL; Neel J
J Am Vet Med Assoc; 2005 Feb; 226(4):562-6. PubMed ID: 15742697
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions in aspirates of malignant lymphomas and benign disorders of the lymph nodes.
Xu LZ; Wang LF
Anal Quant Cytol Histol; 1992 Apr; 14(2):148-52. PubMed ID: 1590898
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors.
Bundgaard-Andersen K; Flagstad A; Jensen AL; Hellmén E; Trerè D
J Vet Intern Med; 2008; 22(5):1174-80. PubMed ID: 18624984
[TBL] [Abstract][Full Text] [Related]
11. Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma.
Starkey MP; Murphy S
Vet Comp Oncol; 2010 Mar; 8(1):56-71. PubMed ID: 20230582
[TBL] [Abstract][Full Text] [Related]
12. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of AgNOR counts and PCNA-positive cell counts in canine malignant lymphomas.
Kiupel M; Bostock D; Bergmann V
J Comp Pathol; 1998 Nov; 119(4):407-18. PubMed ID: 9839202
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric immunophenotype of canine lymph node aspirates.
Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
[TBL] [Abstract][Full Text] [Related]
15. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
Mourad WA; Sneige N; Katz RL; Ordóñez NG
Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
[TBL] [Abstract][Full Text] [Related]
16. What is your diagnosis? Lymph node aspirates from a dog with prominent lymphadenomegaly.
Attipa C; Brooks F; Wilson A; Skulberg R; English K
Vet Clin Pathol; 2017 Dec; 46(4):641-642. PubMed ID: 28741308
[No Abstract] [Full Text] [Related]
17. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone.
Smith J; Kiupel M; Farrelly J; Cohen R; Olmsted G; Kirpensteijn J; Brocks B; Post G
Vet Comp Oncol; 2017 Mar; 15(1):36-45. PubMed ID: 25643820
[TBL] [Abstract][Full Text] [Related]
18. Lymph node cytology.
Cowell RL; Dorsey KE; Meinkoth JH
Vet Clin North Am Small Anim Pract; 2003 Jan; 33(1):47-67, v. PubMed ID: 12512376
[TBL] [Abstract][Full Text] [Related]
19. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
20. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]